[go: up one dir, main page]

ES8104189A1 - Un procedimiento para la preparacion de derivados de feneta-nolamina - Google Patents

Un procedimiento para la preparacion de derivados de feneta-nolamina

Info

Publication number
ES8104189A1
ES8104189A1 ES490214A ES490214A ES8104189A1 ES 8104189 A1 ES8104189 A1 ES 8104189A1 ES 490214 A ES490214 A ES 490214A ES 490214 A ES490214 A ES 490214A ES 8104189 A1 ES8104189 A1 ES 8104189A1
Authority
ES
Spain
Prior art keywords
formula
preparation
phenethanolamines
formulations
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES490214A
Other languages
English (en)
Other versions
ES490214A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES490214A0 publication Critical patent/ES490214A0/es
Publication of ES8104189A1 publication Critical patent/ES8104189A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/06Preparation of carboxylic acid nitriles from N-formylated amino compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/38Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/487Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/04Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE FENETANOLAMINA DE FORMULA GENERAL: *FORMULA* O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO, DONDE R1 ES HIDROGENO O FLUOR, R2 ES METILO O ETILO, R3 ES HIDROXI, ALCANOILOXI, AMINOCARBONILO, METILAMINOCARBONILO O ALCOXICARBONILO. CONSISTE EN SOMETER A REACCION DE REDUCCION UN COMPUESTO DE FORMULA: *FORMULA* ESTE COMPUESTO TIENE APLICACION PARA CONTROLAR EL PESO DE LOS MAMIFEROS.
ES490214A 1978-07-03 1980-04-01 Un procedimiento para la preparacion de derivados de feneta-nolamina Expired ES8104189A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92167078A 1978-07-03 1978-07-03

Publications (2)

Publication Number Publication Date
ES490214A0 ES490214A0 (es) 1981-04-16
ES8104189A1 true ES8104189A1 (es) 1981-04-16

Family

ID=25445792

Family Applications (4)

Application Number Title Priority Date Filing Date
ES482156A Expired ES482156A1 (es) 1978-07-03 1979-07-03 Un procedimiento para la preparacion de nuevos derivados de-fenetanolamina.
ES482155A Expired ES482155A1 (es) 1978-07-03 1979-07-03 Un procedimiento para la preparacion de derivados de feneta-nolamina.
ES490215A Granted ES490215A0 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de derivados de feneta-nolamina
ES490214A Expired ES8104189A1 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de derivados de feneta-nolamina

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES482156A Expired ES482156A1 (es) 1978-07-03 1979-07-03 Un procedimiento para la preparacion de nuevos derivados de-fenetanolamina.
ES482155A Expired ES482155A1 (es) 1978-07-03 1979-07-03 Un procedimiento para la preparacion de derivados de feneta-nolamina.
ES490215A Granted ES490215A0 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de derivados de feneta-nolamina

Country Status (31)

Country Link
EP (3) EP0006766B1 (es)
JP (2) JPS559097A (es)
KR (1) KR880002310B1 (es)
AR (4) AR225744A1 (es)
AT (2) AT372937B (es)
AU (2) AU523721B2 (es)
BE (2) BE877394A (es)
BG (4) BG31375A3 (es)
CA (2) CA1142954A (es)
CH (2) CH643529A5 (es)
CS (4) CS208664B2 (es)
DD (2) DD144761A5 (es)
DE (2) DE2964604D1 (es)
DK (2) DK160936C (es)
EG (1) EG14238A (es)
ES (4) ES482156A1 (es)
FI (2) FI792081A7 (es)
FR (3) FR2430411A1 (es)
GB (3) GB2101582B (es)
GR (2) GR72940B (es)
HU (2) HU179172B (es)
IE (2) IE48769B1 (es)
IL (2) IL57671A (es)
LU (2) LU81458A1 (es)
NZ (2) NZ190861A (es)
PH (2) PH15275A (es)
PL (4) PL117551B1 (es)
PT (2) PT69843A (es)
RO (4) RO83052B (es)
SU (4) SU965350A3 (es)
ZA (2) ZA793296B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006735B1 (en) * 1978-06-28 1983-06-15 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
EP0028105B1 (en) * 1979-10-25 1983-01-19 Beecham Group Plc Secondary amines, their preparation and use in pharmaceutical compositions
EP0029320B1 (en) * 1979-11-15 1985-07-10 Beecham Group Plc Secondary ethanol amines, their preparation and their use in pharmaceutical compositions
EP0040000B1 (en) * 1980-05-08 1983-10-12 Beecham Group Plc Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions
DE3264364D1 (en) * 1981-03-06 1985-08-01 Beecham Group Plc Arylethanol amine derivatives, their preparation and use in pharmaceutical compositions
EP0061907B1 (en) * 1981-03-31 1984-08-01 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
EP0070133B1 (en) * 1981-07-11 1986-05-14 Beecham Group Plc Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
EP0089154A3 (en) * 1982-03-12 1984-08-08 Beecham Group Plc Ethanolamine derivatives, their preparation and use in pharmaceutical compositions
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
JPS5980640A (ja) * 1982-09-27 1984-05-10 イーライ・リリー・アンド・カンパニー 2−ヒドロキシ−2−フエニルエチルアミン類の製造方法
DE3481754D1 (de) * 1983-01-31 1990-05-03 Lilly Co Eli Wachstumsfoerderung von tieren mit phenaethanolaminen.
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
US4602044A (en) * 1983-12-19 1986-07-22 Eli Lilly And Company β-phenethanolamine antiobesity agents
JPS60158153A (ja) * 1984-01-12 1985-08-19 イーライ・リリー・アンド・カンパニー 変力剤
ES8800842A1 (es) * 1985-03-01 1987-12-01 Beecham Group Plc Un procedimiento para preparar una formulacion veterinariamente aceptable de ariletanolaminas promotora del crecimiento.
GB8505284D0 (en) * 1985-03-01 1985-04-03 Beecham Group Plc Growth promoters
IT1204416B (it) * 1986-06-27 1989-03-01 Midy Spa Medicamenti a base di analoghi di feniletanolammine per il trattamento di disturbi gastro-intestinali ed uterini
JP2837408B2 (ja) * 1987-05-30 1998-12-16 鐘紡株式会社 アクリル系繊維の処理方法
US5135955A (en) * 1988-04-25 1992-08-04 Eli Lilly And Company Propanamine derivatives
FI892341L (fi) * 1988-06-10 1989-12-11 Hoffmann La Roche Propanolaminderivat.
US5191112A (en) * 1989-10-17 1993-03-02 Nissan Chemical Industries, Ltd. Process for optical resolution of (±)-2-(3-benzoyl)-phenylpropionic acid
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
ATE312347T1 (de) * 1991-08-23 2005-12-15 Nps Pharma Inc Screening-verfahren für kalzium-rezeptor aktive verbindungen
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
HU228150B1 (en) 1994-10-21 2012-12-28 Nps Pharma Inc Calcium receptor-active compounds, medicaments comprising them, and the use of said medicaments
EP0907631B1 (en) * 1996-05-01 2003-06-18 Nps Pharmaceuticals, Inc. Inorganic ion receptor-active compounds
US7321065B2 (en) * 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL56308C (es) * 1941-03-15
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
GB1301134A (en) 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES
BE788850A (fr) * 1972-09-15 1973-03-15 Hoffmann La Roche Derives d'acide benzoique
IE39247B1 (en) * 1973-05-07 1978-08-30 Allen & Hanburys Ltd Substituted benzamides
US4000192A (en) * 1973-05-07 1976-12-28 Allen & Hanburys Limited Pharmacologically active compounds
NZ190854A (en) * 1978-06-28 1984-10-19 Beecham Group Ltd 2-hydroxy-2-phenyl ethylamine derivatives;pharmaceutical compositions
IL57673A0 (en) * 1978-07-03 1979-10-31 Lilly Co Eli Optically active phenethanolamines and method for increasing cardiac contractility

Also Published As

Publication number Publication date
NZ190861A (en) 1981-12-15
BE877394A (fr) 1980-01-02
IL57671A (en) 1982-11-30
PL121297B1 (en) 1982-04-30
IL57672A (en) 1983-03-31
DK268679A (da) 1980-01-04
FR2430411A1 (fr) 1980-02-01
RO83051A (ro) 1984-02-21
HU179172B (en) 1982-08-28
FI792082A7 (fi) 1981-01-01
GB2028799B (en) 1982-09-08
PL216811A1 (es) 1980-08-25
GB2101582B (en) 1983-06-08
IE48586B1 (en) 1985-03-20
RO83052B (ro) 1984-02-28
GB2101582A (en) 1983-01-19
HU179171B (en) 1982-08-28
PH14522A (en) 1981-08-26
AU523720B2 (en) 1982-08-12
BG31375A3 (bg) 1981-12-15
ATA463579A (de) 1983-04-15
JPS6254095B2 (es) 1987-11-13
CH642618A5 (fr) 1984-04-30
ES482155A1 (es) 1980-08-16
BG31645A3 (bg) 1982-02-15
AT372937B (de) 1983-11-25
AT367025B (de) 1982-05-25
AR227165A1 (es) 1982-09-30
RO77732A (ro) 1981-11-24
CS208662B2 (en) 1981-09-15
ZA793296B (en) 1981-02-25
JPS559096A (en) 1980-01-22
EP0048037A1 (en) 1982-03-24
CS208664B2 (en) 1981-09-15
PT69843A (en) 1979-07-01
CS208663B2 (en) 1981-09-15
FR2430410A1 (fr) 1980-02-01
CS209815B2 (en) 1981-12-31
DK160936C (da) 1991-10-21
ES8104190A1 (es) 1981-04-16
ES490214A0 (es) 1981-04-16
LU81458A1 (fr) 1979-10-30
DE2964091D1 (en) 1982-12-30
NZ190863A (en) 1982-05-25
DD144762A5 (de) 1980-11-05
AR229080A1 (es) 1983-06-15
RO83052A (ro) 1984-02-21
AU4848779A (en) 1980-01-10
KR880002310B1 (ko) 1988-10-22
EP0006766A1 (en) 1980-01-09
CA1142954A (en) 1983-03-15
AU4848979A (en) 1980-01-10
FR2430410B1 (fr) 1986-03-21
FI792081A7 (fi) 1981-01-01
AR231434A1 (es) 1984-11-30
GB2028799A (en) 1980-03-12
EG14238A (en) 1983-12-31
IE791227L (en) 1980-01-03
CA1145767A (en) 1983-05-03
EP0007204B1 (en) 1982-11-24
GB2028802A (en) 1980-03-12
IL57672A0 (en) 1979-10-31
BG31647A3 (bg) 1982-02-15
PT69839A (en) 1979-07-01
IE48769B1 (en) 1985-05-15
BE877393A (fr) 1980-01-02
ATA463679A (de) 1981-10-15
PL117551B1 (en) 1981-08-31
ZA793297B (en) 1981-02-25
FR2430411B1 (es) 1983-08-19
SU849997A3 (ru) 1981-07-23
FR2450806A1 (fr) 1980-10-03
FR2450806B1 (fr) 1985-07-12
RO77728A (ro) 1981-11-24
GR72940B (es) 1984-01-16
PL117997B1 (en) 1981-09-30
DK160936B (da) 1991-05-06
PL216814A1 (es) 1980-03-24
PL117996B1 (en) 1981-09-30
ES490215A0 (es) 1981-04-16
EP0007204A1 (en) 1980-01-23
IL57671A0 (en) 1979-10-31
RO83051B (ro) 1984-02-28
EP0006766B1 (en) 1983-01-26
SU1007554A3 (ru) 1983-03-23
SU957761A3 (ru) 1982-09-07
BG31646A3 (bg) 1982-02-15
KR830001187A (ko) 1983-04-29
GR74524B (es) 1984-06-29
GB2028802B (en) 1983-03-30
AR225744A1 (es) 1982-04-30
PH15275A (en) 1982-11-02
LU81457A1 (fr) 1979-10-30
IE791228L (en) 1980-01-03
JPS559097A (en) 1980-01-22
DE2964604D1 (en) 1983-03-03
DK268779A (da) 1980-01-04
CH643529A5 (fr) 1984-06-15
DD144761A5 (de) 1980-11-05
SU965350A3 (ru) 1982-10-07
ES482156A1 (es) 1980-08-16
AU523721B2 (en) 1982-08-12

Similar Documents

Publication Publication Date Title
ES8104189A1 (es) Un procedimiento para la preparacion de derivados de feneta-nolamina
NO812311L (no) Bronchospasmolytisk virksomme forbindelser og fremgangsmaate for deres fremstilling
DK164937C (da) Analogifremgangsmaade til fremstilling af 1-alkyl-2-aminotetralinderivater eller farmaceutisk acceptable syreadditionssalte deraf samt 1-alkyl-2-aminotetralinderivater til anvendelse som udgangsmateriale i fremgangsmaaden
ES8607914A1 (es) Un procedimiento de preparar un derivado de trans-1,2-diaminociclohexil-amida.
ES8600211A1 (es) Un procedimiento para la preparacion de nuevos derivados arilfenilicos
ES8404361A1 (es) Un procedimiento para la preparacion de un derivado de cefalosporina.
ATE116657T1 (de) 7-keto- und 7-hydroxy-androsta-3,5-dien-3- carbonsäure derivate.
SE8801515D0 (sv) Farmaceutisk komposition
DK161382C (da) Fremgangsmaade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
ES8301200A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
AR240815A2 (es) Procedimiento para preparar derivados de los acidos benzofuran-5-il y benzotiofen-5-il acetico y propionico
ES482420A1 (es) Un procedimiento para la preparacion de 4-desoxi-4-acilamino-derivados de eritromicilamina.
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
SE7904543L (sv) Nya joniska bensen-polyjodidderivat for anvendning som kontrastmedel vid rontgenbehandling
ES8405406A1 (es) Procedimiento para la preparacion de nuevas 4-fenil-4,5,6,7-tetrahidro-tieno(2,3-c)piridinas sustituidas con radicales basicos
ES486580A1 (es) Un procedimiento para preparar compuestos con propiedades broncodilatadoras
MX9203068A (es) Compuestos activirales oralmente activos.
ES8201525A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,1'-bifenil-2-il-alquilamina
ES8609288A1 (es) Un procedimiento para preparar un derivado de tiazolidina
ES458389A1 (es) Procedimiento para preparar derivados de prostaglandina.
ES8506756A1 (es) Procedimiento para preparar derivados de afidicolina.
SE8002689L (sv) 16-metoxi-16-metyl-prostaglandin e?711-derivat, forfarande for framstellning derav och deras anvendning som gastroskyddande medel
ES8307203A1 (es) "un procedimiento para la fabricacion de una difenilamina".
ES467519A1 (es) Un procedimiento de preparacion de acidos furoil- o tenoil- naftiloxialcohilcarboxilicos.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020304